1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

Cell lines tested with tanespimycin:bortezomib (250:1 mol/mol)

797 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
IGROV-1 ovary CTRPv22
Download CSV

Tissues tested with tanespimycin:bortezomib (250:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
lungCTRPv2142
haematopoietic and lymphoid tissueCTRPv2135
N/ACTRPv247
central nervous systemCTRPv245
skinCTRPv244
pancreasCTRPv240
large intestineCTRPv239
ovaryCTRPv238
breastCTRPv237
stomachCTRPv232
Download CSV
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA WWC1 CTRPv2 AAC -0.21 4e-06
mRNA LAMA5 CTRPv2 AAC -0.19 1e-05
mRNA EPS8L2 CTRPv2 AAC -0.18 5e-05
mRNA NBR1 CTRPv2 AAC -0.18 5e-06
mRNA DNAJB2 CTRPv2 AAC -0.18 6e-06
mRNA MANBAL CTRPv2 AAC -0.18 0.0002
mRNA TM9SF4 CTRPv2 AAC -0.17 5e-06
mRNA CEP295NL CTRPv2 AAC -0.17 0.0001
mRNA CYTH3 CTRPv2 AAC -0.17 2e-05
mRNA NEDD9 CTRPv2 AAC -0.17 6e-06
Download CSV